These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9024932)

  • 1. Effect of lactic acid in tumours on antitumour activity of hyperthermia.
    Hirokawa K; Kageyama K; Nakajima T; Tsumura M; Onoyama Y
    Int J Hyperthermia; 1997; 13(1):115-23. PubMed ID: 9024932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lactic acid in tumours on antitumour activity of hyperthermia.
    Vaupel P
    Int J Hyperthermia; 1997; 13(2):247-8. PubMed ID: 9147150
    [No Abstract]   [Full Text] [Related]  

  • 3. Acute changes of systemic parameters in tumour-bearing rats, and of tumour glucose, lactate, and ATP levels upon local hyperthermia and/or hyperglycaemia.
    Krüger W; Mayer WK; Schaefer C; Stohrer M; Vaupel P
    J Cancer Res Clin Oncol; 1991; 117(5):409-15. PubMed ID: 1909697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Granulocyte-colony stimulating factor enhances anti-tumour effect of hyperthermia.
    Takada Y; Sato EF; Nakajima T; Hosono M; Tsumura M; Inoue M; Yamada R
    Int J Hyperthermia; 2000; 16(3):275-86. PubMed ID: 10830589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hyperthermia on the lactic acid and beta-hydroxybutyric acid content in tumour.
    Lee SY; Ryu KH; Kang MS; Song CW
    Int J Hyperthermia; 1986; 2(2):213-22. PubMed ID: 3794417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of vascular endothelial growth factor (VEGF) by hyperthermia and/or an angiogenesis inhibitor.
    Kanamori S; Nishimura Y; Okuno Y; Horii N; Saga T; Hiraoka M
    Int J Hyperthermia; 1999; 15(4):267-78. PubMed ID: 10458567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumour-growth inhibition by induced hyperglycaemia/hyperlactacidaemia and localized hyperthermia.
    Mueller-Klieser W; Walenta S; Kelleher DK; Dinh H; Marx E; Vaupel P
    Int J Hyperthermia; 1996; 12(4):501-11. PubMed ID: 8877474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumour effect of irradiation followed by hyperglycemia and hyperthermia: the dependence on tumour size and blood flow.
    Kozin SV; Zaitsev AV; Yarmonenko SP
    Int J Hyperthermia; 1996; 12(1):147-56. PubMed ID: 8676002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour pH drop after cryotreatment and enhancement of hyperthermia antitumour effect.
    Osinsky SP; Rikberg AB; Bubnovskaja LN; Trushina VA
    Int J Hyperthermia; 1993; 9(2):297-301. PubMed ID: 8468511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of tumour blood flow changes induced by step-up and step-down heating.
    Kozin SV; Borisov MB; Hasegawa T; Ha-Kawa SK; Tanaka Y
    Int J Hyperthermia; 1996; 12(1):139-46. PubMed ID: 8676001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of an angiogenesis inhibitor (TNP-470) and hyperthermia.
    Nishimura Y; Murata R; Hiraoka M
    Br J Cancer; 1996 Feb; 73(3):270-4. PubMed ID: 8562329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioluminescence imaging of metabolites in a human tumour xenograft after treatment with hyperthermia and/or the radiosensitizer pimonidazole.
    Tamulevicius P; Streffer C
    Int J Hyperthermia; 1997; 13(2):235-45. PubMed ID: 9147149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microregional distributions of glucose, lactate, ATP and tissue pH in experimental tumours upon local hyperthermia and/or hyperglycaemia.
    Schaefer C; Mayer WK; Krüger W; Vaupel P
    J Cancer Res Clin Oncol; 1993; 119(10):599-608. PubMed ID: 8335679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of tumour blood flow with KB-R8498 potentiates the response of tumours to hyperthermia.
    Shakil A; Ogawa A; Griffin RJ; Song CW
    Int J Hyperthermia; 1999; 15(1):1-6. PubMed ID: 10193752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour pO2 can be increased markedly by mild hyperthermia.
    Iwata K; Shakil A; Hur WJ; Makepeace CM; Griffin RJ; Song CW
    Br J Cancer Suppl; 1996 Jul; 27():S217-21. PubMed ID: 8763884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment of IL-1 alpha and TNF-alpha potentiates the antitumour effect of hyperthermia.
    Lin JC; Park HJ; Song CW
    Int J Hyperthermia; 1996; 12(3):335-44. PubMed ID: 9044903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation.
    Teicher BA; Pfeffer MR; Alvarez Sotomayor E; Herman TS
    Int J Hyperthermia; 1991; 7(5):773-84. PubMed ID: 1834752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumour effectiveness of hyperthermia is potentiated by local application of electric pulses to LPB tumours in mice.
    Karner KB; Lesnicar H; Cemazar M; Sersa G
    Anticancer Res; 2004; 24(4):2343-8. PubMed ID: 15330182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of tetrahydraindazolone dicarboxylic acid (HIDA) to improve the therapeutic effect in vivo of combined cisplatin, heat and radiation treatment.
    Overgaard J; Radacic M; Skaric D; Skaric V; Horsman MR; Lindegaard JC; Jercic J
    Int J Hyperthermia; 1993; 9(6):821-30. PubMed ID: 8106823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergism between alkylating agent and cis-platin with moderate local hyperthermia: the effect of multidrug chemotherapy in an animal system.
    Matsushita S; Reynolds R; Urano M
    Int J Hyperthermia; 1993; 9(2):285-96. PubMed ID: 8468510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.